ijms-logo

Journal Browser

Journal Browser

The Role of Inflammasomes in Human Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 276

Special Issue Editor


E-Mail Website
Guest Editor
University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
Interests: inflammasome; cancer survivors; melatonin; mitochondria; cardiovascular research

Special Issue Information

Dear Colleagues,

The inflammasomes are innate immune system receptors/sensors that regulate the activation of caspase-1 and induce inflammation in response to infectious microbes and molecules derived from host proteins. Extensive studies have demonstrated that inflammasomes play a vital role in aging, as well as infectious and autoimmune diseases, including type 2 diabetes, Alzheimer's disease, and atherosclerosis. 

By releasing pro-inflammatory cytokines, inflammasomes contribute to the initiation and maintenance of local or systemic inflammation. This inflammatory milieu has been shown to have a role in dampening anti-tumor immunity and suppressing tumor development. However, inflammasomes have also been linked to cell proliferation, alterations in transcriptional activity, stimulation of angiogenesis, and ultimately to the promotion of tumor cell survival and metastasis. Our intention is to provide a friendly and open forum for sharing high-quality manuscripts that address every possible aspect of this complex dual role of the inflammasome activity. Full research papers, impactful communications, comprehensive systematic reviews, or featured opinions are particularly welcome. The main Special Issue topics are as follows:

  1. The role of the inflammasome in resistance to influenza virus infection;
  2. The role of inflammasomes in cancer pathogenesis;
  3. Activation and regulatory mechanism of the inflammasome in chronic inflammatory diseases;
  4. Molecular mechanisms of novel therapeutic approaches for cancer treatment targeting inflammasomes.

Dr. Marisol Fernández-Ortiz
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • inflammasome
  • IL-1 cytokines
  • inflammatory caspases
  • inflammasome activity manipulation

Published Papers

This special issue is now open for submission.
Back to TopTop